Synapse Open Synapse
Biology

Celldex sinks as safety concerns cloud immune drug results

BioPharma Dive · · 3 min read

Though barzolvolimab displayed what one analyst described as the best efficacy results to date against chronic skin hives, treatment was also associated with two life-threatening anaphylaxis cases.

Latest from BioPharma Dive